Old Web
English
Sign In
Acemap
>
Paper
>
PMO-14 Use of non-invasive surrogate markers to monitor vedolizumab therapy in inflammatory bowel disease
PMO-14 Use of non-invasive surrogate markers to monitor vedolizumab therapy in inflammatory bowel disease
2021
J. Barragry
K. Fragkos
G Sebepos-Rogers
Hajeena Saravanapavan
Hui Fen Koo
Ho Juen Ko
I Parisi
Edward Seward
Sara McCartney
Stuart Bloom
Shameer Mehta
Farooq Rahman
Keywords:
Gastroenterology
Medicine
Inflammatory bowel disease
Internal medicine
non invasive
Vedolizumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]